DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20182593

Congenital hepatoblastoma in a neonate

Manas Maruti Shanbhag, Subba Rao

Abstract


Hepatoblastoma is a rare cause of mass abdomen and distension of abdomen in neonates. In this report, a 1-day-old baby who presented with abdominal distension at birth is being described for its unusual presentation. Diagnosis of hepatoblastoma in the antenatal period is possible with the available imaging modalities such as ultrasound abdomen. Caesarean section is recommended when HBL is antenatally diagnosed as vaginal delivery may cause tumor rupture. Beckwith-Wiedemann syndrome, hemihypertrophy and low birth weight are common associations of HBL. Serum Alpha feto protein (AFP) is the most useful laboratory test for hepatoblastoma and hepatocellular carcinoma. AFP is produced in the fetal liver and yolk sac, and levels decline to adult values during the first 6 months after birth. AFP can be used as a tumour marker for screening and confirmation of diagnosis though it is not a very specific tumour marker. Hepatoblastoma should be considered in the differential diagnosis when a neonate presents with distension of abdomen.

Keywords


Abdominal distension, Beckwith-Wiedemann syndrome, Hepatoblastoma

Full Text:

PDF

References


Atkinson JB, Deugarte DA. In: Pediatric surgery. In Grosfeld JL, O neill JA Jr, Coran AG, Fonkaslrud EW, editors. 6thed. Mosby; 2006:502.

Sallam A, Paes B, Bourgeois J. Neonatal hepatoblastoma: two Cases with a review of the literature. Am J Perinatol. 2005;22:413-9.

Al-Salem AH. An illustrated guide to pediatric surgery. Springer; 2014 Sep 24.

Ergin H, Yildirim B, Dagdeviren E, Yagci B, Ozen F, Sen N et al. A prenatally detected case of congenital hepatoblastoma. Pathol Oncol Res. 2008;14:97-100.

Avni FE, Massez A, Cassart M. Tumours of the fetal body: a review. Pediatr Radiol. 2009;39:1147-57.

Ammann RA, Plaschkes J, Leibundgut K. Congenital hepatoblastoma: A distinct entity? Med Pediatr Oncol. 1999;32:466-8.

Huang LC, Ho M, Chang WC, Chen HY, Hung YC, Chiu TH. Prenatal diagnosis of fetal hepatoblastoma with a good neonatal outcome: case report and narrative literature review. Pediatr Hematol Oncol. 2011;28:150-4.

Ansell P, Mitchell CD, Roman E, Simpson J, Birch JM, Eden TO. Relations between perinatal and maternal characteristics and hepatoblastoma: a report from the UKCCS. Eur J Cancer. 2005;41:741-8.

Buckley JD, Sather H, Ruccione K, Rogers PC, Haas JE, Henderson BE et al. A case‐control study of risk factors for hepatoblastoma. A report from the childrens cancer study group. Cancer. 1989 Sep;64(5):1169-76.

Stocker JT, Conran RM. Hepatoblsatoma. In: Okuda K, Tabor E, editors. Liver cancer PA:Churchchill Livingstone;1997:263-78.

Albrecht S, von Schweinitz D, Waha A, Kraus JA, von Deimling A, Pietsch T. Loss of maternal alleles on chromosome arm 11p in hepatoblastoma. Cancer Res. 1994 Oct 1;54(19):5041-4.

Gray SG, Eriksson T, Ekström C, Holm S, Von Schweinitz D, Kogner P et al. Altered expression of members of the IGF-axis in the hepatoblastoma. Br J Cancer. 2000;82:1561-7.

Honda S, Arai Y, Haruta M, Sasaki F, Ohira M, Yamaoka H et al. Loss of imprinting of IGF2 correlates with hypermethylation of the H19 differentially methylated region in hepatoblastoma. British journal of cancer. 2008 Dec;99(11):1891.

Shih JC, Tsao PN, Huang SF, Yen BL, Lin JH, Lee CN, et al. Antenatal diagnosis of congenital hepatoblastoma in utero. Ultrasound Obstet Gynecol. 2000;16:94-7.

Huang LC, Ho M, Chang WC, Chen HY, Hung YC, Chiu TH. Prenatal diagnosis of fetal hepatoblastoma with a good neonatal outcome: case report and narrative literature review. Pediatr Hematol Oncol. 2011;28:150-4.